← back to search

Stella M. Papa

Emory University · US
Area of research
Neurology · Cellular and Molecular Neuroscience
Research interest
Research interests include Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments, Neuroscience and Neuropharmacology Research, and Neurotransmitter Receptor Influence on Behavior.
h-index
27
citations
2,985
works
72
NIH funding
primary concept
email

Recent publications

Research Priorities on the Role of α‐ <scp>Synuclein</scp> in Parkinson's Disease Pathogenesis
Movement Disorders 2024cited by 24position: middledoi
Recent Advances in the Development of Stem‐Cell‐Derived Dopaminergic Neuronal Transplant Therapies for Parkinson's Disease
Movement Disorders 2021cited by 55position: middledoi
Discussion of Research Priorities for Gait Disorders in Parkinson's Disease
Movement Disorders 2021cited by 43position: lastdoi
Addressing the Challenges of Clinical Research for Freezing of Gait in Parkinson's Disease
Movement Disorders 2021cited by 27position: lastdoi
COVID-19 Vaccination for Persons with Parkinson’s Disease: Light at the End of the Tunnel?
Journal of Parkinson s Disease 2021cited by 26position: lastdoi
Impact of the <scp>COVID</scp>‐19 Pandemic on Parkinson's Disease and Movement Disorders
Movement Disorders 2020cited by 158position: firstdoi
Impact of the <scp>COVID</scp>‐19 Pandemic on Parkinson's Disease and Movement Disorders
Movement Disorders Clinical Practice 2020cited by 53position: firstdoi
Striatal Oscillations in Parkinsonian Non-Human Primates
Neuroscience 2020cited by 23position: lastdoi
Role of striatal ΔFosB in <scp>l</scp> -Dopa–induced dyskinesias of parkinsonian nonhuman primates
Proceedings of the National Academy of Sciences 2019cited by 39position: lastdoi
Structurally Distinct α‐Synuclein Fibrils Induce Robust Parkinsonian Pathology
Movement Disorders 2019cited by 36position: middledoi
A Selective Phosphodiesterase 10A Inhibitor Reduces <scp>L</scp>‐Dopa‐Induced Dyskinesias in Parkinsonian Monkeys
Movement Disorders 2018cited by 28position: lastdoi
TRH Analog, Taltirelin Protects Dopaminergic Neurons From Neurotoxicity of MPTP and Rotenone
Frontiers in Cellular Neuroscience 2018cited by 27position: middledoi
Antidyskinetic Effects of MEK Inhibitor Are Associated with Multiple Neurochemical Alterations in the Striatum of Hemiparkinsonian Rats
Frontiers in Neuroscience 2017cited by 25position: middledoi
Physiology of freezing of gait
Annals of Neurology 2016cited by 201position: middledoi
Human striatal recordings reveal abnormal discharge of projection neurons in Parkinson’s disease
Proceedings of the National Academy of Sciences 2016cited by 84position: lastdoi
Dual κ‐agonist/μ‐antagonist opioid receptor modulation reduces levodopa‐induced dyskinesia and corrects dysregulated striatal changes in the nonhuman primate model of<scp>P</scp>arkinson disease
Annals of Neurology 2015cited by 51position: middledoi
Dopamine regulates distinctively the activity patterns of striatal output neurons in advanced parkinsonian primates
Journal of Neurophysiology 2014cited by 55position: lastdoi
Modeling Parkinson's disease in monkeys for translational studies, a critical analysis
Experimental Neurology 2013cited by 71position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Arun Singh · University of South Dakota6 papers (2013–2020)Patrik Brundin · Michigan State University4 papers (2020–2021)Un Jung Kang · AOL (United States)4 papers (2020–2021)Roy N. Alcalay · University of Alabama at Birmingham3 papers (2020–2021)Lisa F. Potts · Spalding University3 papers (2013–2019)Hideki Mochizuki · Neurological Surgery3 papers (2019–2021)Stewart A. Factor · Emory University3 papers (2016–2021)Serge Przedborski · Columbia University3 papers (2021–2021)Lorraine V. Kalia · University Health Network3 papers (2021–2024)Xuebing Cao · Nanjing Tech University3 papers (2014–2018)Mark Hallett · National Institute of Neurological Disorders and Stroke3 papers (2016–2021) · 3 papers (2020–2021) · 2 papers (2016–2021)Han‐Lin Chiang · Westmead Hospital2 papers (2020–2020)Alice Nieuwboer · Neuroelectronics Research Flanders2 papers (2021–2021)John G. Nutt · Oregon Health & Science University2 papers (2021–2021)Nir Giladi · Neurim Pharmaceuticals (Israel)2 papers (2021–2021) · 2 papers (2020–2020)M. Maral Mouradian · Johnson University2 papers (2015–2019)Simon J.G. Lewis · The University of Sydney2 papers (2021–2021)